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Candida albicans is a human opportunistic fungus and it is responsible for a wide variety
of infections, either superficial or systemic. C. albicans is a polymorphic fungus and its
ability to switch between yeast and hyphae is essential for its virulence. Once C. albicans
obtains access to the human body, the host serum constitutes a complex environment
of interaction with C. albicans cell surface in bloodstream. To draw a comprehensive
picture of this relevant step in host-pathogen interaction during invasive candidiasis,
we have optimized a gel-free shaving proteomic strategy to identify both, human
serum proteins coating C. albicans cells and fungi surface proteins simultaneously. This
approach was carried out with normal serum (NS) and heat inactivated serum (HIS).
We identified 214 human and 372 C. albicans unique proteins. Proteins identified in
C. albicans included 147 which were described as located at the cell surface and 52
that were described as immunogenic. Interestingly, among theseC. albicans proteins, we
identified 23 GPI-anchored proteins, Gpd2 and Pra1, which are involved in complement
system evasion and 7 other proteins that are able to attach plasminogen to C. albicans
surface (Adh1, Eno1, Fba1, Pgk1, Tdh3, Tef1, and Tsa1). Furthermore, 12 proteins
identified at the C. albicans hyphae surface induced with 10% human serum were
not detected in other hypha-induced conditions. The most abundant human proteins
identified are involved in complement and coagulation pathways. Remarkably, with this
strategy, all main proteins belonging to complement cascades were identified on the
C. albicans surface. Moreover, we identified immunoglobulins, cytoskeletal proteins,
metabolic proteins such as apolipoproteins and others. Additionally, we identified more
inhibitors of complement and coagulation pathways, some of them serpin proteins (serine
protease inhibitors), in HIS vs. NS. On the other hand, we detected a higher amount of
C3 at the C. albicans surface in NS than in HIS, as validated by immunofluorescence.
Keywords: Candida albicans, shaving, surface proteins, human serum, complement pathways, coagulation
pathways, GPI-anchored proteins, host-pathogen interaction
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INTRODUCTION
The yeast Candida albicans is the most important opportunistic
fungi, causing a wide variety of infections ranging from
superficial to invasive candidiasis, and it is often found in
the mucosal microbiota. C. albicans infections produce high
morbidity and mortality in intensive care, post-surgery and
cancer patients or other types of immunocompromised patients
(Leleu et al., 2002; Almirante et al., 2005; Hube, 2006; Brown
et al., 2012). The high mortality of these infections is determined
by the diagnostic limitations, the scarcity of antifungal agents
and the emergence of resistance to them (Viudes et al., 2002;
Wilson et al., 2002). For these reasons, the incidence of invasive
candidiasis is still high.
The cell wall of C. albicans is a dynamic and complex multi-
layered structure located external to the plasma membrane. It
is responsible for maintenance of the shape that characterizes
each growth form (mainly yeast and hyphae) of the fungus (Klis
et al., 2009). The cell wall mediates the first contact with the
environment and integrates multiple cues into complex signaling
networks that are coordinated by various transcription factors.
Consequently, C. albicans differentially expresses cell surface
proteins and virulence factors. The dimorphic transition that
is the ability of C. albicans to reversibly switch from yeast
to hyphal growth is essential for virulence; strains that are
locked in either form are avirulent (Yan et al., 2013; Lu et al.,
2014). The hyphal form allows the pathogen to penetrate into
tissues to acquire nutrients or escape from the host defense,
and yeast cells disseminate across the human body. There are
many signals capable of inducing the dimorphic phenotypic
switch: N-acetyl-D-glucosamine, physiological temperature and
pH (37◦C and neutral), high CO2 concentration, hypoxia and
nutrient starvation; nonetheless, growing in human serum is the
most physiological condition to study this process (Kumamoto
and Vinces, 2005; Karkowska-Kuleta et al., 2009; Sudbery, 2011;
Mayer et al., 2013; Ene et al., 2014).
C. albicans is able to adhere to host cells and tissues; for
this reason, it exposes surface proteins such as adhesins and
many other pathogenic factors (Chaffin, 2008). Adhesion to host
tissue is a prerequisite for tissue invasion and infection. Among
adhesins, there are the Als family (agglutinin-like sequence),
the Hwp family and the Iff/Hyr family (de Groot et al.,
2013). Pathogenic factors include tissue-digesting hydrolytic
enzymes such as the Sap family (Secreted Aspartyl Proteinases)
(Kretschmar et al., 2002; Buu and Chen, 2014), lipases and
phosholipases. The Sap family is composed of 10 proteins with
different expression patterns; they act optimally at acidic pH.
Their main role is related to digesting molecules for nutrient
acquisition and for digesting or distorting host cell membranes
to avoid or resist antimicrobial attack by the host immune
system (Naglik et al., 2003). Some adhesins are attached to the
wall through a C-terminus glycosylphosphatidylinositol (GPI)
anchorage sequence (De Groot et al., 2003; Pardo et al., 2004; Klis
et al., 2009).
Human serum is a very complex body fluid; its qualitative
and quantitative composition was a hot topic of study during
years (Anderson and Anderson, 2002; Mitchell, 2010). In the
Plasma Proteome Database, proteomic data of 10,546 proteins
detected in human serum and plasma are collected (Nanjappa
et al., 2014). The dynamic range of abundance of these proteins
has more than 10 orders of magnitude of variation. The
complement system is an efficient component of the innate
immune response and establishes a link with the adaptive
system. The three conventional pathways by which complement
is activated (classical, alternative and lectin) are composed of
around 30 proteins (Engleberg et al., 2012). It mediates several
physiological processes such as tissue regeneration and clearance
of immune complexes. C2 and factor B (FB) are the main heat-
sensitive complement components (Soltis et al., 1979). C2 is
the central component in the activation of classical and lectin
pathways and FB is for alternative pathway; both are necessary
for the formation of C3- and C5-convertases in the respective
complement cascades aforementioned.
C. albicans develops several strategies to evade the
complement system, delay the detection by the host immune
systems and even capable of manipulate the host defenses
for its own purpose (Collette and Lorenz, 2011). In this way,
C. albicans acquires host-derived inhibitory proteins such as
factor H (FH), factor H-like protein 1 (FHL-1) and C4b-binding
protein (C4BP), to prevent activation of complement pathways
on its surface. These three protein regulators are closely related
molecules composed of variable numbers of short consensus
repeat (SCR) domains. There are four C. albicans proteins
described with the ability to fix FH on their surface: glycerol
3-phosphate-dehydrogenase 2 (Gpd2), high-affinity gluthathione
transporter 1 (Hgt1), phosphoglycerate mutase 1 or complement
regulator-acquiring surface protein 1 (Gpm1/CRASP1) and
pH-regulated antigen 1 (Pra1/CRASP2) (Poltermann et al., 2007;
Luo et al., 2009, 2013). With the exception of Hgt1, the other
three are able also to bind plasminogen. Additionally, Pra1 and
Hgt1 bind C4BP (Lesiak-Markowicz et al., 2011; Luo et al., 2011).
Factor Hmediates binding to polyanions (sialic acids and human
heparin) present on C. albicans cell wall (Soares et al., 2000;
Rodríguez de Córdoba et al., 2004; Green et al., 2013). Pra1 also
binds fibrinogen and C3 directly (Zipfel et al., 2011).
The aim of this study is to know the human serum protein
coat on C. albicans surface as well as which C. albicans proteins
could be candidates for diagnostic markers, potential vaccines
or therapeutic targets, as they are detected when human serum
is present. The interaction between human serum proteins and
other microorganism surface was tested by different proteomic
approaches in Staphylococcus aureus and Streptococcus pyogenes
(Dreisbach et al., 2011; Sjöholm et al., 2014). In this work,
we carried out a gel-free proteomic approach by shaving live
C. albicans cells with trypsin after serum interaction to obtain
exposed peptides of C. albicans and human proteins. With this
shaving strategy that was applied in our laboratory to C. albicans
and S. cerevisiae cultured in synthetic media (Hernáez et al.,
2010; Insenser et al., 2010; Gil-Bona et al., 2015), it is not
necessary to perform sub-cellular fractionation. In the present
work, we have optimized this protocol for the detection of
C. albicans and human proteins together in conditions that
mimic in vivo interaction during systemic infections; overall,
372 C. albicans and 214 human proteins were identified. Among
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C. albicans proteins, 147 are described as located at the cell
surface. Interestingly Pra1 and Gpd2 are able to attach inhibitors
of complement cascades and plasminogen; while a further 7
proteins are also capable of attaching plasminogen. Regarding
human proteins, all main proteins of complement pathways
were identified, and many proteins involved in coagulation
and metabolism, as well as immunoglobulins or cytoskeletal
proteins. Furthermore, in this work proteins of complement and
coagulation pathways were observed surrounded the surface of
C. albicans hyphal cells.
MATERIALS AND METHODS
Candida albicans Strain and Growth
Conditions
The C. albicans strain used in this work was SC5314, from a
clinical isolate (Gillum et al., 1984). This strain was grown on
YPD plates (2% D-glucose, 2% peptone, 1% yeast extract, and
2% agar) and incubated at 30◦C. A colony was picked and
grown in YPD medium at 30◦C and 200 rpm during 6–8 h. The
OD600 nm wasmeasured and diluted onminimummedium (MM)
at 0.00003 OD600 nm (2% D-glucose, 0.17% yeast nitrogen base,
0.5% (NH4)2SO4, 0.192% synthetic complete mixture (Kaiser)
drop-out -ura and 0.01% uracil). Culture was grown at 30◦C
and 200 rpm overnight to obtain and collected at a concentration
∼106 cells/ml. 1.5 × 107 cells were resuspended in 9ml of Lee
medium at pH 6.7 (Lee et al., 1975). One milliliter of human
serum was added and the culture was grown during 5 h at 37◦C
and 200 rpm. Human sera were from healthy donor volunteers
who did not have any clinical or microbiological evidence of
infection. They were used in the experiments as normal serum
(NS) or heat inactivated serum (HIS). Serum inactivation was
done by heating at 56◦C during 30min in a water bath.
Surface Shaving
Surface shaving procedure was adapted from previous
experiment of our group (Hernáez et al., 2010; Gil-Bona
et al., 2015). Briefly, after incubation of C. albicans with 10%
human serum (normal serum-NS or heat inactivated serum-
HIS), the cultures were centrifuged at 3500 rpm 5min. Cell
pellet was resuspended in 1ml of phosphate buffer saline (PBS)
with 0.1% Tween 20, centrifuged again and washed 6 times
more with PBS. The last pellet was resuspended in 400µl of
ammonium bicarbonate (AMBI buffer; NH4HCO3) 25mM pH
8.0 and 7.5µl dithiothreitol (DTT) 1M and 9µg of recombinant
sequencing grade trypsin (Roche) were added. DTT was added
during the digestion as reducing agent to consent deep digestion
of non-covalently or disulphide bridges associated protein. The
samples were incubated at 37◦C, 30min and 600 rpm. After
incubation, samples were centrifuged at 5000 rpm 5min and
the supernatant was filtered with a filter unit of 0.22µm. The
cell pellet was resuspended in 400µl of fresh AMBI buffer and
100µl of trifluoroacetic acid (TFA) 0.1% (v/v) were added to stop
the proteolytic reaction. It was centrifuged and the supernatant
was filtered again. Both peptide-supernatants were put together
and processed for further proteomic analysis. Subsequently,
originated peptides were cleaned up with a Poros R2 resin
(ABSciex, Framingham, MA). Peptides were eluted with 80%
acetonitrile in 0.1% TFA, dried in a Speed-Vac and resuspended
in 0.1% formic acid. The samples were stored at −20◦C before
nano-LC-MS/MS analysis.
LTQ-Orbitrap Velos Analysis, Protein
Identification, and Bioinformatics Analysis
Peptides were analyzed by nano-LC-MS/MS analysis. Peptide
samples were concentrated and desalted using C18-A1 ASY-
column 2 cm pre-column (Thermo Scientific) and then eluted
onto a Biosphere C18 column (Nano-Separations). Peptides were
separated with a 140min gradient (110min from 0 to 40% Buffer
B; Buffer A: 0.1% formic acid/2% acetonitrile; Buffer B: 0.1%
formic acid in acetonitrile) at a flow-rate of 250 nl/min on
a nano-Easy HPLC (Proxeon) coupled to a nano-electrospray
ion source (Proxeon). Mass spectrometry experiments were
performed using a LTQ-Orbitrap Velos (Thermo Scientific) in
the positive ion mode. Full-scan MS spectra (m/z 400/1400)
were acquired in the Orbitrap apparatus with a target value
of 1,000,000 at a resolution of 60,000 at m/z 400 and the 15
most intense ions were selected for collision induced dissociation
(CID) fragmentation in the LTQ with a target value of 10,000 and
normalized collision energy of 38%. Precursor ion charge state
screening and monoisotopic precursor selection were enabled.
Singly charged ions and unassigned charge states were rejected.
Dynamic exclusion was enabled with a repeat count of 1 and
exclusion duration of 30 s.
Protein identification was carried out with mass spectra raw
files using a licensed version of search engine MASCOT 2.3.0
with Proteome Discoverer software version 1.4.1.14 (Thermo
Scientific). Searchers were made against C. albicans SC5314
(6221 sequences) and human database (20233 sequences)
available on Candida Genome Database (Assembly 21 of
CGD, http://www.candidagenome.org/) and Uniprot-SwissProt
(http://www.uniprot.org) respectively, to identify peptides and
proteins. Search parameters were oxidizedmethionine as variable
modification, peptide mass tolerance 10 ppm, 2 missed trypsin
cleavage sites and MS/MS fragment mass tolerance of 0.8
Da. In all protein identification, the FDR was <1%, using
a Mascot Percolator, with a q-value of 0.01. Gene Ontology
(GO) terms at CGD (http://www.candidagenome.org/cgi-bin/
GO/goTermFinder) were used to classify C. albicans proteins.
As an estimation of the relative protein abundances
the normalized spectral abundance factor (NSAF) was used
(Zybailov et al., 2007), and the average of the normalized values
was calculated. Mass spectrometry proteomics data have been
deposited in C. albicans PeptideAtlas (Vialas et al., 2014) with the
data set identifier PASS00446.
Cell Permeability
Before and after trypsin treatment, C. albicans cell wall
permeability was evaluated by staining with propidium iodide
(PI). 106 cells/ml were incubated with 10µl of PI 5mM and the
positive fluorescent cells (red staining) were checked, at least 200
cells of each sample were counted in a fluorescence microscope.
Frontiers in Microbiology | www.frontiersin.org 3 December 2015 | Volume 6 | Article 1343
Marín et al. Human Serum Proteins on C. albicans
Cells treated with 70% ethanol-PBS (v/v) were used as positive
control.
Epifluorescence and Confocal
Fluorescence Microscopy
For detecting complement proteins on C. albicans surface after
interaction with human serum, a solution of 106 cells/ml on Lee
medium at pH 6.7 with 10% of human serum (NS or HIS) was
prepared. 105 cells of this suspension were laid during 30min, 1.5
or 5 h at 37◦C on glass coverslips pre-coated with poly-L-lysine
(1mg/ml). Cells were fixed with formaldehyde 4% (w/v) (in PBS)
for 20min at room temperature (RT). Glass slides were washed
twice with PBS. To stain cell membrane, PKH26 dye was added
following technical instructions (Sigma Aldrich). Then, slides
were blocked during 45min at RT with buffer B (PBS plus bovine
serum albumin (BSA) at 1mg/ml). The slides were washed twice
again with PBS and then incubated for 1.5 h at RT in the same
buffer with an anti-C3, anti-factor B polyclonal serum (dilution
1:75 and 1:50, respectively) or only buffer. The slides were washed
three times with PBS and further incubation for 1 h with an anti-
rabbit IgG conjugated with Alexa-488 diluted at 1:500 in buffer B
was done. Nuclei were stained with DAPI dye (5µg/ml; 5min
at RT). Mounting medium Fluoromount-G (SouthernBiotech)
was added to the preparations. Cells were then examined with
epifluorescence and confocal microscopy images were collected
using an Olympus FV1200 microscope.
Flow Cytometry Analysis
C. albicans cells were grown as previously described on
Immunofluorescence assay section. In this case the incubation
with human serum (NS or HIS) was done during 30min to avoid
larger hyphae formation. After that, cells were washed with PBS
and fixed with formaldehyde 4% in PBS during 20min at RT.
Then, three washes with PBS were performed and samples were
blocked with 0.1% BSA in PBS at 4◦C overnight with gentle
shaking. Samples were incubated with primary antibody or with
buffer alone as negative control, for 2 h at RT. The primary
antibodies were prepared in PBS with 0.1% BSA, anti-C3 and
anti-FB at 1:75 and 1:50 dilutions, respectively. Four PBS washes
were performed and incubated with secondary antibody below,
an anti-rabbit conjugated with Alexa-488 diluted at 1:500, 2 h at
RT with gently shaking. Then, samples were washed with PBS
4 times more. These cells were analyzed with a Guava easyCyte
cytometer of Millipore.
RESULTS
Gel-free Proteomic Approach to Study
Protein Interactions between C. albicans
and Human Serum
In order to break through the broad spectrum of human
serum proteins attached to C. albicans cells and the fungus
surface proteins, we analyzed C. albicans cell surface after 5 h
of incubation with 10% human serum by a gel-free proteomic
strategy. Normal serum (NS) was used to mimic physiological
conditions of C. albicans during invasive candidiasis and heat
inactivated serum (HIS) to determine human proteins deposited
on the C. albicans surface without conventional complement
cascade activation. As human serum is the most important
inductor of C. albicans dimorphic transition, after 5 h of
incubation all C. albicans cells were in the hyphal form. To
obtain the protein peptides, a shaving methodology was used,
which consists of direct cell digestion with trypsin and MS/MS
identification. Before digestion, cells were washed with PBS
plus Tween-20 and several additional washes with PBS were
done to remove human serum proteins weakly attached to
C. albicans cells. We optimized parameters such as time and
trypsin concentration during shaving of C. albicans cells, in
order to control cell integrity and identify the highest number
of proteins (from both, C. albicans and human). With short times
of trypsin treatment, between 5 and 10min, only human proteins
were identified (data not shown). Otherwise, after 30min, human
and C. albicans proteins were detected; thus, this duration
of trypsin incubation was selected. Before and after trypsin
treatment, cells were treated with propidium iodide (PI) and the
cell permeability state was analyzed under the microscope. Less
than 1% positive staining was obtained in all conditions. Cell
integrity was assessed with the purpose of avoiding cytoplasmic
protein contamination after trypsin treatment.
Peptides obtained after C. albicans cells interaction with 10%
human serum (NS or HIS) by shaving were recovered and
identified by LC-MS/MS on a LTQ Orbitrap. Four biological
replicates were made using NS and three using HIS. Mass
spectra raw files were searched against C. albicans SC5314 and
human databases (CGD and Uniprot-SwissProt, respectively)
and proteins identified in at least two biological replicates with
two or more peptides in one of them were selected. C. albicans-
identified proteins are listed in Table 1 and Table S1, and human
proteins in Table 2 and Table S2.
This analysis rendered the identification of 372 unique C.
albicans proteins, 371 in NS and 134 in HIS (Table S1). There
were 133 proteins identified in both conditions, accounting for
36% of the total C. albicans-identified proteins. The Orf19.8 (an
ortholog of C. dubliniensis CD36) was the only protein identified
with HIS and not with NS. Noteworthy, around ∼33% of the
C. albicans proteins were identified in at least six of the seven
analyzed samples. Furthermore, of the 372 C. albicans-identified
proteins, 60 proteins presented a signal peptide (SP) at CGD. On
the other hand, 214 human proteins were identified; of these, 128
were common to both conditions (60%), 43 were present only
after incubation with NS and the other 43 only with HIS (Table 2
and Table S2).
Analysis of C. albicans Cell Surface Protein
Pattern after Interaction with 10% human
Serum
Only those C. albicans identified proteins with a Gene Ontology
(GO) annotation at CGD pointing either to surface localization,
either to surface exposure or with the ability to induce human
serum antibodies, were included in Table 1. We focused our
study on these 155C. albicans proteins classified into 5 categories:
glycosylphosphatidylinositol (GPI)-anchored proteins; proteins
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TABLE 1 | Selected C. albicans proteins identified after incubation with 10% NS or HIS related with cell surface and immunogenicity.
Categories Common in NS and HIS Only identified in NS Only in HIS Total
GPI-anchored proteinsa 11 12 – 23
Als3, Cht2, Ecm33, Hyr1, Ihd1, Pga45, Phr1,
Pir1, Rbt1, Rbt5, Sod5
Als1, Crh11, Pga10, Pga4, Phr2, Plb3, Plb4.5,
Rhd3, Sap9, Ssr1, Utr2, Ywp1
–
Proteins involved in cell wall organization
or biogenesisb(GO: 71554)
8 18 – 26
Act1, Bmh1, Gda1, Msb2, Sod1, Srb1, Tsa1,
Yps7
Agm1, Bgl2, Eng1, Frs1, Gfa1, Gsc1, Kex2,
Mnn26, Mnt1, Pmi1, Pmt2, Ras1, Rho1,
Rvs161, Sim1, Slk19, Sur7, Ypt31
–
Cell surface proteinsb(GO: 9986) 40 21 1 62
Adh1, Cdc19, Cdc48, Cef3, Ddr48, Ece1,
Efb1, Eft2, Egd2, Eno1, Fba1, Glx3, Hsp70,
Hsp90, Ino1, Ipp1, Kar2, Met6, Mp65,
Orf19.2478.1, Pdc11, Pdi1, Pgk1, Pma1,
Pra1, Rpl10, Rpl17B, Rpl3, Rpl4B, Rps7A,
Rps8A, Sam2, Ssa2, Ssb1, Tal1, Tdh3, Tef1,
Tkl1, Tos1, Tpi1
Ape2, Atp1, Atp2, Coi1, Csp37, Gpd2, Gph1,
Hem13, Hsp104, Hsp21, Rpl13, Rpl14,
Rpl19A, Rpl20B, Rpl6, Rps10, Rps6A, Ssc1,
Ssz1, Ugp1, Xyl2
Cht3
Plasma membrane proteinsb (GO: 5886) 8 28 – 36
Ahp1, Orf19.6553, Cof1, Met15, Pfy1, Pgi1,
Pil1, Tif
Ade17, Adh2, Bcy1, Bzz1, Cdc42, Chc1,
Faa4, Gca1, Hgt6, Ist2, Kin2, Lsp1, Mdg1,
Orf19.1564, Orf19.3003, Orf19.4216,
Orf19.6160, Pet9, Pga63, Pst3, Rdi1, Sec26,
Sec4, Shm2, Sso2, Tom70, Ypt1, Ykt6
–
Others immunogenic proteins 6 2 – 8
Asc1, Gnd1, Grp2, Hxk2, Msi3, Sah1 Acs2, Mdh1 –
155
The classification is hierarchical and exclusive. Proteins were included if they were detected in at least two replicates of one condition with at least 2 peptides in one replicate. There are
four replicates of Normal Serum (NS) and three replicates of Heat Inactivated Serum (HIS). Protein names from Candida Genome Database (CGD) (Inglis et al., 2012).
aGPI-cell wall proteins reviewed in De Groot et al. (2003), Pardo et al. (2004), Chaffin (2008), Klis et al. (2009).
bGene Ontology (GO) terms (in parentheses the GO identifier) at CGD.
Proteins able to induce human serum antibodies in patients with invasive candidiasis are indicated in bold (Pitarch et al., 2004, 2006, 2008, 2011; Mochon et al., 2010).
involved in cell wall organization or biogenesis; cell surface
proteins; plasma membrane proteins and other immunogenic
proteins not present in the previous group. The groups are
hierarchical and exclusive.
The first category includes 23 proteins attached to the plasma
membrane or cell wall by a GPI-anchor; most are involved in
biogenesis and maintenance of the C. albicans cell wall. All GPI-
anchored proteins identified have a detected SP for entry into the
secretory pathway at CGD. In the second category, there are 26
other proteins involved in cell wall organization or biogenesis.
Among the 62 proteins included in the cell surface category,
there are proteins located at the cell surface, although most of
them do not have SP and could not reach this cell localization
via the secretory pathway. Several of them have been described
as “moonlighting” or multifunctional proteins. It is interesting
that antibodies against a total of 52 C. albicans-identified proteins
have been detected in human blood or serum from patients with
invasive candidiasis (these immunogenic proteins are highlighted
inTable 1). Many of these are abundant at the cell surface (as they
were detected with more than 10 unique peptides) and were not
secreted by the classical secretory pathway (not have SP), such as
Eno1, Fba1, Hsp70, and 17 additional proteins.
It is also remarkable that two out of the four proteins described
in C. albicans with the ability to fix the complement inhibitor
factor H (FH) were identified. Pra1 was identified in both samples
(NS and HIS), but Gpd2 was only in NS samples. Furthermore,
we detected many C. albicans proteins described with the ability
to bind plasminogen: Adh1, Eno1, Fba1, Gpd2, Pgk1, Pra1, Tdh3,
Tef1, and Tsa1.
Analysis of Human Serum Proteins that
Interact with C. albicans Cell Surface
Relevant to C. albicans-host Interaction
The 214 identified human proteins were classified into the
following classes according to their function: complement
pathway, coagulation pathway, metabolism, immunoglobulins,
cytoskeleton, and others. Proteins belonging to complement
and coagulation cascades are listed in Table 2 and the rest
of the proteins are in Table S2. The percentages of proteins
identified in each category in the two conditions tested are
shown in Figure 1. The complement and coagulation pathways
represent higher percentages of the total identified proteins when
HIS was used and, on the other hand, the immunoglobulin
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TABLE 2 | Human proteins of complement and coagulation pathways identified on the surface of C. albicans after incubation with human serum.
Accession
numbera
Gene symbola Description/Functiona No. replicates (peptides on each replicate)b
NS HIS
COMPLEMENT PATHWAY
P01023 A2M Alpha-2-macroglobulin 2 (15,11) 3 (10,9,70)
P04003 C4BPA C4b-binding protein alpha chain 4 (5,3,4,9) 3 (15,8,4)
P20851 C4BPB C4b-binding protein beta chain 1 (2) 2 (2,3)
P10909 Clusterin Extracellular chaperone or ApoJ 4 (11,8,13,19) 3 (11,13,18)
Q9BWP8 COLEC11 Collectin kidney protein 1 or collectin-11 4 (5,5,2,4) 0
P02745 C1qA Complement C1q subcomponent subunit A 0 2 (1,4)
P02746 C1qB Complement C1q subcomponent subunit B 3 (1,1,1) 3 (5,5,4)
P02747 C1qC Complement C1q subcomponent subunit C 3 (1,1,2) 3 (7,5,6)
P00736 C1r Complement C1r subcomponent 2 (2,7) 3 (21,15,14)
Q9NZP8 C1r-like Complement C1r-like protein 0 3 (6,5,5)
P09871 C1s Complement C1s subcomponent 2 (1,10) 3 (23,14,11)
P06681 C2 Complement component C2 1 (2) 3 (19,15,10)
P01024 C3 Complement component C3 4 (103,106,141,147) 3 (141,105,138)
P0C0L4 C4-A Complement component C4-A 4 (32,32,94,98) 3 (90,61,76)
P0C0L5 C4-B Complement component C4-B 4 (32,33,95,98) 2 (90,62)
P01031 C5 Complement component C5 3 (34,23,21) 3 (68,46,70)
P13671 C6 Complement component C6 3 (20,18,4) 3 (21,14,16)
P10643 C7 Complement component C7 4 (13,9,8,6) 3 (6,11,16)
P07357 C8-A Complement component C8 alpha chain 4 (13,11,6,7) 3 (11,8,8)
P07358 C8-B Complement component C8 beta chain 4 (5,6,16,27) 3 (22,16,13)
P07360 C8-G Complement component C8 gamma chain 4 (6,6,4,1) 3 (6,4,9)
P02748 C9 Complement component C9 4 (17,15,17,22) 3 (24,17,14)
P00751 FB Complement factor B 4 (8,3,8,10) 3 (47,31,28)
P00746 FD Complement factor D 0 3 (2,2,4)
P08603 FH Complement factor H 2 (5,3) 3 (18,17,13)
P05156 FI Complement factor I 1 (1) 3 (3,3,6)
P27918 FP Complement factor P or Properdin 4 (5,5,2,2) 1 (3)
Q15485 Ficolin-2 Collagen/fibrinogen domain containing protein 2 0 2 (1,3)
O75636 Ficolin-3 Collagen/fibrinogen domain containing protein 3 1 (1) 3 (5,2,7)
O00187 MASP2 Mannan-binding lectin serine protease 2 3 (2,2,5) 1 (3)
P80108 GPLD1 Phosphatidylinositol-glycan-specific phospholipase D 0 2 (4,15)
P05155 C1INH Plasma protease C1 inhibitor (Serpin G1) 0 3 (20,14,24)
P04004 VTN Vitronectin or protein S 4 (10,12,10,11) 3 (14,11,13)
COAGULATION PATHWAY
P01009 SERPINA1 Alpha-1-antitrypsin (AAT) 4 (4,3,6,12) 3 (37,35,47)
P08697 SERPINF2 Alpha-2-antiplasmin 4 (2,2,9,13) 3 (17,16,18)
P01008 SERPINC1 Antithrombin-III (AT-III) 4 (2,2,5,10) 3 (13,16,25)
P02749 ApoH Beta-2-glycoprotein 1; APC inhibitor; Apolipoprotein H 2 (1,1) 3 (8,3,4)
Q96IY4 CPB2 Carboxypeptidase B2; Thrombin-activable fibrinolysis inhibitor 4 (2,1,12,10) 3 (5,3,3)
P00740 F9 Coagulation factor IX 4 (3,2,3,5) 3 (5,4,4)
P12259 F5 Coagulation factor V 4 (8,2,11,22) 3 (11,4,8)
P08709 F7 Coagulation factor VII 2 (2,3) 2 (3,2)
P00742 F10 Coagulation factor X 2 (2,2) 3 (6,6,6)
P00748 F12 Coagulation factor XII 1 (1) 2 (4,8)
P00488 F13A Coagulation factor XIII A chain 3 (1,2,1) 2 (4,7)
P05160 F13B Coagulation factor XIII B chain 0 3 (2,1,2)
P02671 FGA Fibrinogen alpha chain 4 (13,12,3,7) 3 (6,6,10)
P02675 FGB Fibrinogen beta chain 4 (13,10,1,7) 3 (6,11,14)
(Continued)
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TABLE 2 | Continued
Accession
numbera
Gene symbola Description/Functiona No. replicates (peptides on each replicate)b
NS HIS
P02679 FGG Fibrinogen gamma chain 3 (6,6,4) 3 (2,5,10)
P02751 FN1 Fibronectin; Binds cell surfaces and various compounds (collagen, fibrin, heparin…) 4 (60,62,15,16) 3 (29,38,24)
P68871 HBB Hemoglobin subunit beta 4 (7,9,3,10) 3 (9,7,11)
Q9Y251 HPA Heparanase 2 (1,3) 0
P05546 HCF2 Heparin cofactor 2 (Serpin D1) 4 (8,11,34,28) 3 (29,23,27)
P04196 HRG Histidine-rich glycoprotein 4 (22,23,26,23) 3 (21,24,17)
Q14520 HABP2 Hyaluronan-binding protein 2 0 3 (4,3,5)
P01042 KNG1 Kininogen-1 4 (6,2,11,15) 3 (11,14,11)
P03952 KLKB1 Plasma kallikrein 4 (7,8,2,1) 3 (8,9,10)
P05154 SERPINA5 Plasma serine protease inhibitor 0 2 (3,6)
P00747 PLG Plasminogen 4 (5,6,21,34) 3 (41,41,15)
P40197 GP5 Platelet glycoprotein V 2 (2,2) 3 (5,2,3)
Q9UK55 SERPINA10 Protein Z-dependent protease inhibitor 4 (1,1,10,9) 3 (6,5,7)
P00734 F2 Prothrombin 4 (16,18,17,25) 3 (21,17,10)
P04070 PROC Vitamin K-dependent protein C 1 (3) 2 (3,4)
P07225 PROS1 Vitamin K-dependent protein S 3 (1,1,11) 3 (6,3,14)
P04275 VWF von Willebrand factor 4 (18,16,19,72) 3 (52,36,9)
aAccession number, gene symbol and function from UniProtKB/Swiss-Prot database (Uniprot, 2014).
bProteins were included if they were identified in at least two replicates of one condition with at least 2 peptides in one replicate.
FIGURE 1 | Percentage representation of human protein groups
identified in normal serum (NS) and heat inactivated serum (HIS)
samples by shaving C. albicans cells. Overall, 171 proteins were identified
in both conditions and were classified into the complement pathway,
coagulation pathway, metabolism, immunoglobulin, cytoskeleton, and others.
group represents a higher percentage when NS was
used.
Close to all components of the three complement pathways
(33 proteins) were identified, most of them in the two
conditions tested. However, there are some complement proteins
that have been detected only in the NS sample (Collectin-
11) or in the HIS sample [complement C1q subcomponent
subunit A (C1qA), complement C1r-like protein, complement
factor D (FD), ficolin-2, phosphatidylinositol-glycan-specific
phospholipase D (GPLD1) and plasma protease C1 inhibitor
(SERPING1 or C1INH)] (Table 3). The identification of many
complement inhibitors such as alpha-2-macroglobulin (A2M),
C1INH, FH, and factor I (FI) is also interesting. In relation to
the coagulation pathway, 31 proteins were identified, with most
of them also being detected in the two conditions. Although
heparanase was only identified in NS sample and coagulation
factor XIII B chain, hyaluronan-binding protein 2 and plasma
serine protease inhibitor (SERPINA5) were only identified in
the HIS one. Interestingly, antithrombin-III (SERPINC1) and
plasminogen (PLG), two coagulation proteins that are relevant
complement inhibitors, were identified. Focusing on human
immunoglobulins IgG and IgM, they were identified in NS and
HIS samples and with a similar number of peptides in both of
them (Table S2). The category of metabolic proteins includes
many apolipoproteins detected on the surface of C. albicans
(Table S2).
Interestingly, 13 proteins belonging to the serpin family were
identified. Serpins are a relevant group of proteins with similar
structures able to inhibit proteases. Some of them had only been
observed in the HIS sample, such as SERPINA5, C1INH and
cortisol-binding globulin (SERPINA6) (Table 4).
To estimate the relative abundance of human proteins
identified on C. albicans surface, the normalized spectral
abundance factor (NSAF) (Zybailov et al., 2007) of each protein
was calculated and the average NSAF values among samples
were assessed. We compared these NSAF values with the ranking
of the original protein abundance in human plasma using data
of the dynamic range of most abundant proteins adapted from
Mitchell (2010). As shown in Figure S1, the relative abundance
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TABLE 3 | Comparison of complement proteins identified on the cell surface of C. albicans by shaving after incubation with NS vs. HIS.
Complement proteins Normal serum (NS) Heat inactivated serum (HIS)
Lectin pathway 7 proteins 7 proteins
Collectin-11, MASP2, Ficolin-3*, C2*, C3, C4-A, C4-B MASP2*, Ficolin-2, Ficolin-3, C2*, C3, C4-A, C4-B
Classical pathway 8 proteins 10 proteins
C1qB, C1qC, C1r, C1s, C2*, C3, C4-A, C4-B C1qA, C1qB, C1qC, C1r, C1r-like, C1s, C2, C3, C4-A, C4-B
Alternative pathway 3 proteins 4 proteins
C3, FB, FP C3, FB, FD, FP*
Membrane attack complex (MAC) 7 proteins 7 proteins
C5, C6, C7, C8-A, C8-B, C8-G, C9 C5, C6, C7, C8-A, C8-B, C8-G, C9
Complement inhibitors 7 proteins 9 proteins
A2M, C4BPA, C4BPB*, clusterin, FH, FI*, vitronectin A2M, C1INH, C4BPA, C4BPB, clusterin, FH, FI, GPLD1, vitronectin
Proteins indicated in bold are only identified in one condition.
Proteins with *are identified only in one replicate of the indicated condition.
TABLE 4 | Identified proteins belonging to the SERPIN family.
Accesion
number
Gene name Protein Substrate No. replicates (peptides on each
replicate)
NS HIS
P01009 SERPINA1 Alpha 1-antitrypsin Human neutrophil elastase 4 (4,3,6,12) 3 (37,35,47)
P01011 SERPINA3 Alpha 1-antichymotrypsin Cathepsin G 2 (1,2) 3 (27,19,30)
P29622 SERPINA4 Kallistatin Kallikrein 2 (5,10) 3 (13,19,16)
P05154 SERPINA5 Plasma serine protease inhibitor Protein C 0 2 (3,6)
P08185 SERPINA6 Cortisol-binding globulin Non-inhibitory; cortisol binding 0 3 (11,8,12)
P05543 SERPINA7 Thyroxine-binding globulin Non-inhibitory; thyroxine binding 2 (2,1) 3 (6,4,14)
P01019 SERPINA8 Angiotensionogen Non-inhibitory; Precursor of angiotensin I 4 (6,5,5,5) 3 (11,13,19)
Q9UK55 SERPINA10 Protein Z-related protease inhibitor Factor Z and XI 4 (1,1,10,9) 3 (6,5,7)
P01008 SERPINC1 Antithrombin-III Thrombin and factors IXa, Xa, and XIa 4 (2,2,5,10) 3 (13,16,25)
P05546 SERPIND1 Heparin cofactor II Thrombin 4 (8,11,34,28) 3 (29,23,27)
P36955 SERPINF1 Pigment epithelium derived factor Non-inhibitory; Potent anti-angiogenic molecule 1 (1) 3 (11,10,19)
P08697 SERPINF2 Alpha 2-antiplasmin Plasmin and trypsin 4 (2,2,9,13) 3 (17,16,18)
P05155 SERPING1 Plasma protease C1 inhibitor C1r, C1s, F12a, kallikrein, F11a, plasmin, MASP1, MASP2 0 3 (20,14,24)
of proteins in the plasma is different to the relative abundance
at the hypha surface after interaction with human serum. For
example, C3 protein of complement pathways was identified as
one of the most abundant proteins on the surface of C. albicans
in both conditions and it was not among the most abundant
proteins in plasma. Also, in the apolipoprotein family, the relative
abundance of some proteins is different in the plasma vs. the
fungal surface. ApoB100 and ApoE are less abundant in human
plasma than ApoCIII and both proteins showed higher NSAF
than ApoCIII.
The abundance ranking of the proteins involved in the
complement and coagulation pathways identified on C. albicans
surface is shown in Figure 2. C3, C4-B, and C4-A had the
highest NSAF results among complement proteins in both serum
conditions. Complement components of Membrane Attack
Complex (MAC: C6, C7, C8-A, C8-B, C8-G, and C9) had
higher NSAF in NS than in HIS samples and only C5 had
higher NSAF in HIS than in NS samples. In the coagulation
pathway, it is notable that SERPINA1 (alpha-1-antitrypsin) is
much more abundant in the HIS sample than other proteins such
as HRG (histidine-rich glycoprotein), HCF2 (SERPIND1) or F2
(prothrombin), which are more abundant in the NS sample than
SERPINA1.
During complement activation, C3, C4, and C5 are
proteolyzed by cleavage at a specific site and small fragments
are produced; these fragments are called anaphylotoxins or
complement peptides, and are indicated with the letter “a”
(Walport, 2001a,b). The analysis of the identified peptides
belonging to: (i) anaphylotoxin regions (C3a, C4a, and C5a), (ii)
released domains during proteolysis activation of complement
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FIGURE 2 | Protein ranking of complement and coagulation proteins
identified on normal serum (NS) and heat inactivated serum (HIS)
samples according to the average of NSAF. C. albicans was incubated
with 10% human serum at 37◦C (normal serum-NS or heat inactivated
serum-HIS) and NSAF was calculated for proteins belonging to complement
and coagulation proteins. The proteins were ordered according to their NSAF
obtained in NS samples, from more to less abundant. Gradient color ranges
from red (more abundant) to green (less abundant).
pathways (C2b and FBa), and (iii) of the MAC-interaction
regions (MACPF) is shown in Table 5. The tendency was the
identification of more peptides belonging to these regions in HIS
samples than in NS samples. It is remarkable that peptides from
C2b and C5a were not identified in NS samples.
Validation of Proteomic Results
To validate the proteomic results, firstly the deposition level
of C3 and FB on the C. albicans surface was analyzed by
immunofluorescence microscopy and flow cytometry assays. C3
is a common component of the three complement cascades
and together with A2M, are the two highest abundant
complement proteins in human serum. Factor B (FB) is
an abundant complement protein specific of the alternative
pathway. C. albicans cells were incubated with NS and HIS
and treated with anti-C3 and anti-FB antibodies (Figure 3). We
observed the deposition of C3 and FB along the surface of all
C. albicans cells when incubated with human serum (NS or HIS)
and some areas with higher intensity in the case of C3 after 5 h
of incubation with NS (Figure 3A, left panels). These differences
TABLE 5 | Analysis of peptides corresponding to cleavage fragments
produced during complement activation and to contact regions in MAC
formation.
Region No. peptides
Normal Serum-NS Heat Inactivated Serum-HIS
Total Only in NS Total Only in HIS
C2b 0 0 4 4
C3a 8 2 10 3
C4a 5 1 4 1
C5a 0 0 5 5
Ba 1 0 5 4
C6-MACPF 13 0 19 6
C7-MACPF 4 0 15 12
C8-A-MACPF 4 0 8 4
C8-B-MACPF 19 1 19 0
Identified peptides belong to the indicated released region or remain part of the full-length
protein.
Gray background highlights identification in HIS condition.
between the fluorescence intensity of FB and C3 can be correlated
with the number of peptides of these proteins in the samples
at 5 h. When cells were incubated with HIS, the intensity of FB
was slightly higher than in the case of NS incubation (it is well
observed in short incubation times) (Figure 3A, right panels). To
achieve flow cytometry assays, the incubation time of C. albicans
cells with human serum was decreased to avoid the formation
of large filaments. Within 30min of incubation, the deposition
of C3 was higher among the population in NS samples than
in HIS (Figure S3). The intensity of FB was lower than that
of C3, as expected, and less homogenous in both samples (NS
and HIS) (upper panels). Mean fluorescence intensity (MFI) of
two independent experiments were collected and showed that,
in all cases, the MFI for C3 and FB was higher when cells
were incubated with NS than with HIS at short times, although
the differences are not significant in the case of FB (bottom
panel).
All of these data together showed that C3 and FB deposition
was clearly observed at short incubation times, and C3 enhanced
its accumulation on the surface with longer incubation time and
more dramatically when the incubation was with NS. However,
FB accumulation onC. albicans surface did not appear to increase
with time, maybe because it can be masked by the rest of the
complement proteins (Figure 3A).
Furthermore, to address whether C3 and FB are close to
the cytoplasmic membrane, fluorescence co-localization was
evaluated with confocal microscopy images by the analysis
of transversal sections across cells (Figure 3B). As observed,
both C3 and FB proteins are localized around the plasmatic
membrane, staining when C. albicans cells were incubated with
NS and also with HIS.
Afterwards, in order to evaluate the deposition of human IgGs
on C. albicans surface after 5 h of incubation with 10% human
serum, IgGs were detected in NS and HIS samples, with higher
intensity on the yeast surface than on the hyphal surface in both
samples (Figure S2).
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FIGURE 3 | Detection of C3 and factor B on C. albicans surface after incubation with human serum. (A) Immunofluorescence assay to detect C3 and factor
B (FB) on C. albicans surface incubated 30min, 1.5 and 5 h with normal serum (NS; left panels) or heat inactivated serum (HIS; right panels). Control images showed
the background of secondary antibody (anti-rabbit-A488). (B) Co-localization of C3 and FB with C. albicans plasmatic membrane (staining with PKH26) was examined
by the analysis of confocal microscopy images, after 5 h of incubation with NS and HIS. Representative images are shown. Yellow arrows indicate position of
transversal sections of illustrative histograms. Co-localization analysis was performed using FiJi software. Red staining of plasmatic membrane was done with PKH26,
blue staining of DNA with DAPI and green staining with anti-rabbit-A488. Line in bottom right corner indicated in all figures corresponds to a 5µm.
DISCUSSION
Our work shows, for the first time to our knowledge, the
identification by a shaving approach of 147 C. albicans surface
proteins and 214 human serum proteins attached to the surface
of the fungus in the same report. The more relevant C. albicans
proteins identified are GPI-anchored proteins and proteins
involved in cell wall organization or biogenesis. The most
relevant human proteins identified belong to complement and
coagulation pathways. Indeed, all main human complement
proteins were identified on the surface of C. albicans. The
identified proteins were reproducible among the experiments and
would represent the physiological mode of action of the immune
system against C. albicans or components of the immune system
used for C. albicans to evade, disturb or use on its own purpose
the host defenses.
Analysis of C. albicans Surface Proteins
With the objective of unraveling the protein surface pattern of
C. albicans hyphal cells, we analyzed our data in comparison to
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the data obtained by our group using the same methodology
of cell shaving over yeast and hyphal cells (growth also in Lee’s
medium, but without human serum) (Gil-Bona et al., 2015). This
analysis rendered 304 proteins identified in all C. albicans assays
(yeasts and hyphae with and without human serum) that we
consider the C. albicans common core of cell surface proteins
and not morphotype specific (Table S3). Also, a hyphal protein
pattern of 55 proteins identified on C. albicans hypha forms, but
not identified in C. albicans yeasts, was obtained. Among them,
Als3, Hyr1, and Sod5 were associated with hyphae in different
works (Heilmann et al., 2011; Sosinska et al., 2011; Sudbery,
2011). They are proteins that are expected to be detected,
indicating that the other 52 proteins are at least more abundant or
accessible in hypha than in yeast cells. Another example is Ece1,
which is a hyphal-specific protein with unknown function (Fan
et al., 2013) (Table S3).
Other proteins were associated with hyphae in some works
and described as morphotype-independent in others, for
example, Phr1 and Rbt1 (Heilmann et al., 2011; Ragni et al., 2011;
Monniot et al., 2013). We identified both proteins in all shaving
C. albicans experiments. Furthermore, Phr2 (a homolog of Phr1)
was also identified in all conditions. The differences observed at
the level of detection of Phr1 and Phr2 among the samples were
possibly related to the optimum pH for expression of each one
(Sosinska et al., 2011; Dühring et al., 2015) (Table S1). On the
other hand, Rhd3 and Ywp1 were reported as yeast-specific and
were found to be part of the common core pattern in our study
(Heilmann et al., 2011). A relevant protein found in C. albicans
common core pattern is Msb2; this stabilizes the fungal cell wall
and inactivates human antimicrobial peptides (Dühring et al.,
2015).
It is interesting to know that GPI-anchored proteins identified
in this work are part of the common core of C. albicans surface
proteins or of the hyphal-form specific ones. There are 17
proteins belonging to the common core in our analysis, and
also Ece1 and Sod5, which are part of the hyphal-specific group,
whose genes were up-regulated under blood growth (Fradin et al.,
2003).
Remarkably, 12 proteins were only identified on the
C. albicans hyphal surface when it was grown with 10% human
serum and we highlighted Pra1, Sap5, Tef1, and 5 more Orfs
with unknown function (Table S3). In this work, two members
of the Sap family, Sap9 and Sap5, were identified. Sap9 is part of
C. albicans common core while Sap5 shows up in hyphae induced
with the human serum group. Both genes were up-regulated in
C. albicans biofilm associated with bloodstream infections (Joo
et al., 2013). Ten out of these twelve proteins are identified for
the first time on the surface of C. albicans; Pra1 and Tef1 have
been previously identified in the cell wall of C. albicans.
Many proteins described as “moonlighting” or
multifunctional proteins in C. albicans were identified in
this work (Nombela et al., 2006; Chaffin, 2008) (indicated
with ∗ in Table S1). Among them, Gpd2 has been described
as a virulence factor on microorganism surface because it
mediates complement evasion; meanwhile, there is a glycerol
3-phosphate-dehydrogenase in the cytoplasm that is involved
in the intracellular accumulation of glycerol to control osmotic
pressure (Luo et al., 2013). Tsa1 is involved in oxidative stress
response in the cytoplasm and in hyphal cell wall biogenesis
(Urban et al., 2005). Tdh3 is a glycolytic enzyme (glyceraldehyde-
3-phosphate dehydrogenase) in the cytoplasm and able to attach
fibronectin and laminin at the cell surface (Gozalbo et al., 1998).
Regarding C. albicans proteins that interact with complement
inhibitor proteins (FH and PLG), the expression of Gpd2 and
Pra1 is more prominent at the hyphal tip (Zipfel et al., 2011; Luo
et al., 2013). Pra1 is also able to bind C4BP and it is also known
that the hyphal tip is a prominent binding site for C4BP (Meri
et al., 2004; Luo et al., 2011). For these reasons and because it
facilitates host tissue penetration, the hyphal tip is considered
an important factor of pathogenesis. We identified these two
proteins on the C. albicans surface grown with 10% human
serum that activate hyphal growth. Focusing on the mechanism
to evade complement activationmediated by plasminogen coated
surfaces, as plasminogen is an important complement cascade
inhibitor in the fluid phase and on the human surface (Barthel
et al., 2012), the identification of nine out of the elevenC. albicans
proteins with the ability to bind PLG (Adh1, Eno1, Fba1, Gpd2,
Pgk1, Pra1, Tdh3, Tef1, and Tsa1) is another highlight of this
study (Crowe et al., 2003; Jong et al., 2003; Barthel et al., 2012).
Human Serum Proteins with the Ability to
Interact with C. albicans Surface
We detected human plasma proteins from different abundance
strata on C. albicans surface; most of them are from the most
abundant proteins or from intermediate stratum (Anderson and
Anderson, 2002; Mitchell, 2010). Due to the heat treatment of
HIS serum, FB and C2 become non-functional; in this situation,
other human serum proteins could interact further with the
surface of C. albicans. Remarkably, C. albicans surface could be
less accessible to trypsin digestion when it was grown with 10%
HIS as the number of coated of human proteins is greater. This
could explain the observation of higher sum of peptide-spectrum
match (PSMs) of human serum proteins in the HIS condition in
comparison with the NS condition. In any case, it is not possible
to discard that some proteins differentially observed in HIS are
a result of changes in their binding properties due to protein
denaturation.
Albumin is the most abundant protein in human plasma with
close to two orders of magnitude more than the rest of proteins
(Mitchell, 2010), but it was not detected as the highest abundant
protein on C. albicans surface incubated with human serum
(either NS or HIS) (Figure S1). Also, there are some proteins
only detected on C. albicans surface in HIS samples that have
intermediate abundance in human plasma such as C1INH, C1qA,
and RBP4. Serotransferrin and fibrinogen (FGG, FGA and FGB)
were more abundant in NS condition and in the other side
apolipoprotein A-I and transthyretin in HIS condition. All of
these data indicate that the interaction between human proteins
and C. albicans surface did not respond solely to their protein
abundance in human serum. The study of C3 and FB deposition
on C. albicans surface after incubation with 10% human serum
was carried out by immunofluorescence with specific antibodies.
The clearly deposition of C3 and FB was observed at short times
of interaction in Figure 3A.
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A graphical summary of the identified proteins at C. albicans
surface from the different complement pathways in NS and
HIS conditions is presented in Figure 4. The enrichment on
the surface of C. albicans in proteins belonging to the lectin,
classical and alternative complement pathways is visibly observed
in normal conditions (NS); almost all of the main proteins of
complement pathways were identified (Figures 4A,B). Peptides
belonging to anaphylotoxin region are less frequently identified
in NS than in HIS condition; this could be related to that C2b,
C3a, FBa, and C5a fragments were released to the medium under
this condition (Table 5). Furthermore, two peptides (CCEDGMR
and CCEDGMRENPMR), which are part of the LRK26 peptide
derived from C3a and with antimicrobial effects on C. albicans
surface (Sonesson et al., 2007), were only identified in NS.
FIGURE 4 | Model of interactions among proteins of the complement pathways identified on C. albicans surface after incubation with human serum.
Proteins identified in normal serum (NS) samples in (A,B). Proteins belonging to lectin and classical pathways are represented in (A) and to alternative pathway in (B).
Proteins mainly identified on heat inactivated serum (HIS) in (C). Identified proteins on samples are indicated with gray background and not-identified in white.
Complement fragments released during complement activation are indicated with triangles. Peptides belonging to complement fragments that can be released or be
part of a full-length protein are indicated with *. Numbers in (A,B) correspond to sequential steps during complement pathways activation. (A) Collectin-11 was only
identified in NS samples. MASP2 was identified in NS and MASP1 was not identified in any sample. Fc (constant region of Ig) of IgGs or IgMs start classical
complement pathway. (B) Properdin was identified in NS and Factor D (FD) was not. (C) Ficolin-2, Ficolin-3, C1qA, C1INH, and FD were identified only in HIS
samples. C1INH dissociates the C1qrs complex, blocks alternative C3 convertase and inhibits C3 activation by kallikrein. C2 was identified in HIS, including 4
peptides of C2b. Five peptides belonging to FBa were identified in HIS condition. Signally, peptides belonging to C5a fragment were only identified in HIS samples.
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Peptides belonging to the C5a region were only identified in HIS
samples, just as more peptides belonging to theMACPF region of
C6, C7, and C8-A. Furthermore, lower NSAF for all components
of MAC, except C5, were obtained with HIS (Figure 2), which
could be correlated with the enhanced identification of C5a
peptides in this condition. In contrast, no identification of
peptides belonging of C5a region and higher NSAF for the
rest of components of MAC in NS samples may indicate
MAC formation. MACPF-domains would not be accessible to
trypsin digestion because they are points of interaction for
MAC formation and would be protected in this condition.
Furthermore, we identified clusterin and vitronectin (VTN) with
higher NSAF in NS condition and both are able to interact with
MAC in plasma, and thus prevent the cytolysis of host cells
(Chauhan and Moore, 2006). Further experiments are required
to determine the formation and the functionality of MAC on
C. albicans surface.
In the same line of thought, in NS samples, properdin (FP) and
not factor D (FD) were identified, while the opposite happened
with HIS samples (Figure 4B vs. Figure 4C). The results are in
agreement with a functional alternative complement pathway
in NS condition on the surface of C. albicans. On the other
hand, in HIS samples, FD could still be attached to the C3bB
complex and we suppose that C3 convertase is not formed. In this
situation, FP could not stabilize the complex and would be not
identified on HIS samples. C1INH is able to bind to immobilized
C3b and block progression of the complement cascade (Jiang
et al., 2001). Serpin role of C1INH produces dissociation of
C1qrs complex and the identification of these proteins in the
HIS condition was enhanced, possibly for this reason. C3 and C4
(C4-A and C4-B) were identified with less NSAF and C2 and FB
with higher NSAF in HIS samples (Figure 4C). In a current study
about Streptococcus pyogenes interaction with human plasma,
C2, C1qA, and FD were not detected on the surface of the
microorganism (Sjöholm et al., 2014). In our experiments, when
C. albicans cells were incubated with HIS, we detected not only
these proteins, but also C1INH, and the enrichment of FB,
C1qB, and C1qC. This is an interesting observation that may be
due to the absence of functional convertases; FB and C2 might
be more accessible to trypsin digestion. We assume that the
unsuitable formation of complement convertases, or at least in
a less extended manner, is responsible for the enhanced peptide
identification of C2, FB, FD, C5, and the C1qrs complex in HIS
samples.
Coagulation and complement pathways are highly connected,
with many cross-talks (Kazatchkine and Jouvin, 1984; Amara
et al., 2008, 2010; Peerschke et al., 2008; Diamond, 2013;
Verschoor and Langer, 2013). Many complement inhibitors
were identified on the surface of C. albicans and in general
more abundant in HIS samples. The innate immune system
strives to respond and activates complement cascades by
non-conventional mechanisms (thrombin (F2), PLG, Factor
XII (F12), kallikrein (KLKB1), ficolin-2 and -3) and bypass
locking points in absence of functional FB and C2 (Nielsen
et al., 1996; Rittirsch et al., 2008) (Figures 2, 4C). In HIS
samples, KLKB1 inhibitors were enriched, such as SERPINA5,
SERPINC1, A2M, and C1INH (Gadjeva et al., 1998; Paréj et al.,
2013).
A relevant group of proteins is serpin family (serine protease
inhibitors), which are broadly distributed among eukaryote
organisms. Serpins are able to inhibit proteases by a specific
mechanism where covalent complexes are formed with target
proteases (Law et al., 2006). Since serpin has to be cleaved
to inhibit the target substrates, inhibition also consumes the
serpin; serpins are therefore irreversible enzyme inhibitors. For
these reasons, the identification of many serpins on C. albicans
surface and more interestingly in HIS samples is an interesting
observation because they may be inactivating their substrates
attached to the surface of C. albicans or themselves coating
C. albicans surface in the sense to avoid interactions between their
substrates and C. albicans (Table 4).
Interestingly, the apolipoproteins classified in the metabolism
group are involved in lipid transport and also play a relevant
role in host defense as part of the innate immune system
(Grunfeld and Feingold, 2008). Furthermore, C. albicans grows
better in lipoprotein-depleted plasma due to two factors: greater
availability of lipids and reduced neutralizing candidacidal factor
(Vonk et al., 2004). ApoE has a relevant role in systemic
candidiasis infection and showed higher NSAF in NS samples
(Figure S1). ApoE-/- mice showed an increased mortality in
comparison with wild type (85 vs. 52%) (Vonk et al., 2004),
and also an impaired immune response in Klebsiella pneumonia
infection (de Bont et al., 2000).
In summary, the mechanisms developed by C. albicans to
evade, interfere or use for its benefit host defenses are very
wide and part of its pathogenic evolution. The analysis of
C. albicans surface after incubation with human serum to obtain
a partial breakdown of the immunological crosstalk between
C. albicans and human serum proteins is a relevant target of
study. C. albicans mimic human immune evasion model using
many surface proteins to fix plasminogen and complement
inhibitors (FH and C4BP) to protect against complement
activation. Furthermore, the identification of Pra1, Sap5, Tef1,
and 9 more proteins only identified in C. albicans hyphal surface
induced with 10% human serum and not in other published
conditions with an equivalent approach is a relevant highlight of
this analysis.
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